Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics
NCT ID: NCT00739752
Last Updated: 2018-11-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1747 participants
INTERVENTIONAL
2003-06-30
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients
NCT00137670
Reducing Sexual Risk Behaviors and Improving Health for People at a Sexually Transmitted Infection Clinic
NCT00947271
HIV Testing & Womens Attitudes on HIV Vaccine Trials
NCT00771537
Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students
NCT00161382
Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
NCT00947947
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Framed-Offered
Non-Framed, Information Only Condition. Vaccine Offered.
Non-Framed-Offered
Subjects received information only and are offered the vaccine.
Non-Framed-Recommended
Non-Framed, Information Only Condition. Vaccine Recommended.
Non-Framed-Recommended
Subjects receive information only and are recommended the vaccine.
Gain-Framed-Offered
Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Offered.
Gain-Framed-Offered
Subjects receive gain-framed messages and are offered the vaccine.
Gain-Framed-Recommended
Gain-Framed Intervention emphasizes the benefits associated with receiving HBV vaccine. Vaccine Recommended.
Gain-Framed-Recommended
Subjects receive gain-framed messages and are recommended the vaccine.
Loss-Framed-Offered
Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Offered.
Loss-Framed-Offered
Subjects receive loss-framed messages and are offered the vaccine.
Loss-Framed-Recommended
Loss-Framed Intervention emphasizes the risks associated with not receiving HBV vaccine. Vaccine Recommended.
Loss-Framed-Recommended
Subjects receive loss-framed messages and are recommended the vaccine.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Framed-Offered
Subjects received information only and are offered the vaccine.
Non-Framed-Recommended
Subjects receive information only and are recommended the vaccine.
Gain-Framed-Offered
Subjects receive gain-framed messages and are offered the vaccine.
Gain-Framed-Recommended
Subjects receive gain-framed messages and are recommended the vaccine.
Loss-Framed-Offered
Subjects receive loss-framed messages and are offered the vaccine.
Loss-Framed-Recommended
Subjects receive loss-framed messages and are recommended the vaccine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No prior self-reported history of HBV immunization or infection
* Fluent in English
* Not known to be HIV positive.
Exclusion Criteria
* Received any prior HBV vaccination
* Prior infection of Hepatitis B
* Unable to read or comprehend the English language
* HIV positive
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gregory Zimet
Professor of Pediatrics & Clinical Psychology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory D Zimet, PhD
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chicago Department of Public Health
Chicago, Illinois, United States
Bell Flower Clinic
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cox AD, Cox D, Zimet G. Promoting prevention and early detection: The impact of message framing, product function and perceived product risk. J Marketing 2006;70:79-91.
Kasting ML, Head KJ, Cox D, Cox AD, Zimet GD. The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial. Prev Med. 2019 Oct;127:105798. doi: 10.1016/j.ypmed.2019.105798. Epub 2019 Aug 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0205-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.